登出

自選
模擬交易
選股器
熱力圖
機構追踪

美股市場個股詳情

VIGL Vigil Neuroscience

添加自選

2.580
-0.130-4.80%

交易中 04/29 14:57 (美東)

9696.75萬總市值-1211市盈率TTM

Vigil Neuroscience股票討論區

登錄發表評論

Dr. Kaufmann's appointment, with her vast experience in neurological and rare diseases, is anticipated to benefit Vigil as it progresses the development of its drugs iluzanebart and VG-3927. Her expertise in both domestic and global drug development is considered a valuable asset for the company.

Press Release: Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer

1

2023/09/26 21:03

Support

$Vigil Neuroscience(VIGL.US)$ Jumped in at 5.10. Finally getting the hang of catching winners. @AmyNic @Biff @Den the Dragon @Firebird (Trixie)@GAME_DAY @Gman511 @iamiam @jimmy the trader @Jenna Ragan @Mcsnacks H Tupack @Megadad2186 @MangoXXX @MooMamaLlama @Ripper @Rivera @StockVader

4

1

2022/08/27 02:09

Very low volume, but I like the setup. I'm going to throw a little something on this one and keep a close eye on it.

$Vigil Neuroscience(VIGL.US)$

3

1

Moomoo IPO Buzz

2022/01/04 18:43

專欄IPO Buzz | 2022 IPO market kicks off with 3 biotechs set to trade on Friday

$Amylyx Pharmaceuticals(AMLX.US)$$CinCor Pharma, Inc.(CINC.US)$$Vigil Neuroscience(VIGL.US)$

IPO Buzz | 2022 IPO market kicks off with 3 biotechs set to trade on Friday

長圖

股票&市場分析

55

6

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

美股

綜合熱度